JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
CALL
Cadence Design Systems
CDNS
$89.5B
| $3.4M | ﹤0.01% |
11,300
+800
| +8% | +$233K |
|
|
CTLP
3602
DELISTED
Cantaloupe
CTLP
| $3.39M | ﹤0.01% |
356,973
+245,579
| +220% | +$2.24M |
|
3603
Lands' End
LE
$384M
| $3.39M | ﹤0.01% |
258,010
+46,094
| +22% | +$723K |
|
3604
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $3.39M | ﹤0.01% |
35,645
+1,251
| +4% | +$121K |
|
3605
PUT
Hershey
HSY
$37B
| $3.39M | ﹤0.01% |
20,000
-30,000
| -60% | -$5.38M |
|
3606
Sabre
SABR
$900M
| $3.38M | ﹤0.01% |
926,730
-603,343
| -39% | -$2.21M |
|
|
EDN
3607
Edenor
EDN
$1.01B
| $3.38M | ﹤0.01% |
78,754
-545
| -0.7% | -$18.6K |
|
3608
Keros Therapeutics
KROS
$200M
| $3.38M | ﹤0.01% |
213,431
+182,314
| +586% | +$9.47M |
|
3609
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.17B
| $3.38M | ﹤0.01% |
44,700
+23,306
| +109% | +$1.78M |
|
|
BFS
3610
Saul Centers
BFS
$860M
| $3.37M | ﹤0.01% |
86,974
+31,308
| +56% | +$1.25M |
|
3611
CALL
Crown Castle
CCI
$32.3B
| $3.36M | ﹤0.01% |
37,000
+36,400
| +6,067% | +$3.81M |
|
3612
Intrepid Potash
IPI
$493M
| $3.34M | ﹤0.01% |
152,199
+129,722
| +577% | +$3.27M |
|
3613
PUT
Louisiana-Pacific
LPX
$5.17B
| $3.33M | ﹤0.01% |
32,200
| – | – |
|
3614
Comstock Resources
CRK
$4.13B
| $3.33M | ﹤0.01% |
182,995
+12,657
| +7% | +$175K |
|
3615
PubMatic
PUBM
$801M
| $3.32M | ﹤0.01% |
226,328
+163,979
| +263% | +$2.54M |
|
3616
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $3.32M | ﹤0.01% |
199,524
+41,999
| +27% | +$745K |
|
3617
Edgewise Therapeutics
EWTX
$4.8B
| $3.32M | ﹤0.01% |
124,435
-34,071
| -21% | -$1.08M |
|
3618
HealthStream
HSTM
$846M
| $3.32M | ﹤0.01% |
104,468
+47,264
| +83% | +$1.46M |
|
3619
Vanguard Total Corporate Bond ETF
VTC
$1.71B
| $3.32M | ﹤0.01% |
43,867
+2,003
| +5% | +$155K |
|
|
RYZ
3620
Ryerson Holding Corp
RYZ
$1.5B
| $3.32M | ﹤0.01% |
179,422
+17,771
| +11% | +$399K |
|
3621
CALL
Dynatrace
DT
$14.2B
| $3.32M | ﹤0.01% |
61,000
+31,000
| +103% | +$1.69M |
|
|
WBND
3622
DELISTED
Western Asset Total Return ETF
WBND
| $3.31M | ﹤0.01% |
169,970
-5,323
| -3% | -$107K |
|
3623
PUT
Medtronic
MDT
$117B
| $3.31M | ﹤0.01% |
41,400
-20,000
| -33% | -$1.73M |
|
3624
PUT
International Paper
IP
$21.6B
| $3.29M | ﹤0.01% |
61,200
| – | – |
|
3625
ProShares S&P 500 ex-Energy ETF
SPXE
$87.7M
| $3.29M | ﹤0.01% |
51,976
-14,440
| -22% | -$917K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.